These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17101077)

  • 1. Patient-reported Outcome Measures in Multiple Sclerosis.
    Riazi A
    Int MS J; 2006 Nov; 13(3):92-9. PubMed ID: 17101077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility and psychometric properties of the Functional Assessment of Multiple Sclerosis for individuals with multiple sclerosis.
    Smith EL; Driskell LD
    Rehabil Psychol; 2016 May; 61(2):218-9. PubMed ID: 27196864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Hidden' factors influencing quality of life in patients with multiple sclerosis.
    Lysandropoulos AP; Havrdova E;
    Eur J Neurol; 2015 Oct; 22 Suppl 2():28-33. PubMed ID: 26374511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of health-related quality of life in children and adolescents].
    Ravens-Sieberer U; Klasen F; Bichmann H; Otto C; Quitmann J; Bullinger M
    Gesundheitswesen; 2013 Oct; 75(10):667-78. PubMed ID: 24129907
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of quality of life measures in multiple sclerosis research.
    Nortvedt MW; Riise T
    Mult Scler; 2003 Feb; 9(1):63-72. PubMed ID: 12617271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reliability and validity of pain interference measures in persons with multiple sclerosis.
    Osborne TL; Raichle KA; Jensen MP; Ehde DM; Kraft G
    J Pain Symptom Manage; 2006 Sep; 32(3):217-29. PubMed ID: 16939846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The symptom inventory disability-specific short forms for multiple sclerosis: construct validity, responsiveness, and interpretation.
    Schwartz CE; Bode RK; Quaranto BR; Vollmer T
    Arch Phys Med Rehabil; 2012 Sep; 93(9):1617-1628.e1. PubMed ID: 22580198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power analysis on the time effect for the longitudinal Rasch model.
    Feddag ML; Blanchin M; Hardouin JB; Sebille V
    J Appl Meas; 2014; 15(3):292-301. PubMed ID: 24992252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcome measures and how they are used.
    Palfreyman S
    Nurs Older People; 2011 Feb; 23(1):31-6. PubMed ID: 21323049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?
    Benedict RH; Walton MK
    Mult Scler; 2012 Dec; 18(12):1673-9. PubMed ID: 22824644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measuring quality of life: as simple as possible and as detailed as necessary].
    Kohlmann T
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(2-3):104-10. PubMed ID: 24780707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients' perspective and economic variables as objectives in clinical trials: added value to clinical parameters].
    Bovaira-García MJ; Soler-Company E
    Rev Calid Asist; 2012; 27(2):92-102. PubMed ID: 22137201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings.
    Gold SM; Schulz H; Stein H; Solf K; Schulz KH; Heesen C
    J Neurol Sci; 2010 Mar; 290(1-2):102-6. PubMed ID: 19922955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of outcome in patients undergoing surgery for intradural spinal tumor using the multidimensional patient-rated Core Outcome Measures Index and the modified McCormick Scale.
    Bellut D; Burkhardt JK; Mannion AF; Porchet F
    Neurosurg Focus; 2015 Aug; 39(2):E2. PubMed ID: 26235018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36).
    Walters SJ; Campbell MJ
    Health Qual Life Outcomes; 2004 Dec; 2():70. PubMed ID: 15588308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of patient-reported outcome assessment in hemophilia care—a state of the art review.
    Bullinger M; Globe D; Wasserman J; Young NL; von Mackensen S
    Value Health; 2009; 12(5):808-20. PubMed ID: 19490552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health-related quality of life as an outcome measure].
    Pedersen AF; Zachariae R; Mainz J
    Ugeskr Laeger; 2005 Nov; 167(48):4545-9. PubMed ID: 16324433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.